期刊文献+

组织芯片技术在临床病理研究中的运用 被引量:4

暂未订购
导出
作者 刘诚
出处 《实用临床医学(江西)》 CAS 2005年第2期130-132,共3页 Practical Clinical Medicine
  • 相关文献

参考文献23

  • 1Kononen J,Bubendorf L,Kallioniemi A,et al.Tissne microarrays for high-throughput molecular profiling of tumor specimens[J].Nat Med,1998,4:844~847.
  • 2刘勇,路名芝.组织芯片技术的建立[J].江西医学检验,2003,21(5):382-384. 被引量:4
  • 3Hoss A,Cordon-Cardo C.Tissne microarry profiling of cancer specimens and cell line:Opportunities and limitation[J].Lad Invest,2001,81:1 331~1 338.
  • 4Henshall S.Tissne Microarrays[J].Jounrnal of Mammary Gland Biology and Meoplasia.2003,8:347~367.
  • 5杨军,王康敏,苏宝山,黄莺,赵世平.组织芯片技术在原位杂交中的应用[J].临床与实验病理学杂志,2002,18(3):344-344. 被引量:10
  • 6Camp RL,Charette LA,Rimm DL.Validation of tissue microarrays techrology in breast Carainoma[J].Lab Invest, 2000,80:1 943~1 949.
  • 7Hoos A,Urist MJ,Stojadinovic A,et al.Validation of tissue microarrays for immunbhistochemical profiling of cancer specimens using the example of human foibroblastic tumors[J].Am J Pathol,2001,158:1 245~1 251.
  • 8Bubendorf L,Kolmer M,Kononen J,et al.Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrys[J].J Natl Cancer lust,1999,91:1 758~1 761.
  • 9Gancberg D,Di Leo A,Rouas G,et al.Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma[J].J Clin Pathol,2002,55:315~317.
  • 10Bubendorf L,Kononen J,Koivisto P,et al.Survey of gene ampliications during prostate cancer progression by high-throughpuut fluorescence in situ hybridisation on tissue microarrays[J].Cancer Res,1999,59:803~806.

二级参考文献19

  • 1Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens[J]. Nat, Med,1998,4:844-847.
  • 2Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays[J]. Cancer Res,1999,59:803-806.
  • 3Moch H, Kononen J, Kallioniemi OP, et al. Tissue microarrays:what will they bring to molecular and anatomic pathology?[J].Adv Anat Pathol,2001,8:14-20.
  • 4Kaio E, Tanaka S, Kitadai Y, et al. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma[J]. Oncology, 2003, 64(1): 61 -73.
  • 5Furndoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced coloreetal carcinoma[J]. Oncology, 2002, 82:157 - 166.
  • 6Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor lalpha in common human cancers and their metastases[J]. Cancer Res, 1999,59:5830 - 5835.
  • 7Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer[J]. Cancer Res, 1995, 3964 -3968.
  • 8Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147:9 - 19.
  • 9Wong MP, Cheung N, Yuen ST, et al. Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumor progression[J]. In J Cancer, 1999, 81:845 -850.
  • 10Andre T. Kotelevets L, Vaillant JC, et al. Vegf, vegf-B, vegf-C and their receptors KDR, FLT-I and FLT-4 during the neoplastic progression of human colonic mucosa[J]. In J Cancer, 2000, 86:174 - 181.

共引文献46

同被引文献10

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部